Axel Bortlein
Stuttgart, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Population-Based Versus Hospital-Based Data in Amyotrophic Lateral Sclerosis-A Factor to Consider?
Journal: European journal of neurology
Published: October 18, 2024
Coping as a resource to allow for psychosocial adjustment in fatal disease: results from patients with amyotrophic lateral sclerosis.
Journal: Frontiers in psychology
Published: December 28, 2023
Population-Based Evidence for the Use of Serum Neurofilaments as Individual Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis.
Journal: Annals of neurology
Published: December 01, 2023
Cystatin C based estimation of chronic kidney disease and amyotrophic lateral sclerosis in the ALS registry Swabia: associated risk and prognostic value.
Journal: Scientific reports
Published: July 03, 2023
Association of blood lipids with onset and prognosis of amyotrophic lateral sclerosis: results from the ALS Swabia registry.
Journal: Journal of neurology
Published: November 28, 2022
Health-Related Quality of Life Outcomes from Botulinum Toxin Treatment in Spasticity.
Journal: Toxins
Published: March 26, 2020
Health-related quality of life outcomes from botulinumtoxin treatment in blepharospasm.
Journal: Clinical neurology and neurosurgery
Published: March 10, 2018
Botulinumtoxin Improves both Generic and Disease-Specific Quality of Life in Cervical Dystonia.
Journal: Frontiers in neurology
Published: April 03, 2017
Health-related quality of life outcomes from botulinum toxin treatment in hemifacial spasm.
Journal: Therapeutic advances in neurological disorders
Published: October 11, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026